Skip to main content

SummitTX Capital, L.P.

Source: SEC Form 13F · as of Mar 2026

SummitTX Capital, L.P. holds 44 biotech & pharma companies tracked by BioSniper, totaling $141.4M in value as of Mar 2026 (SEC Form 13F).

Companies held

44

Total value held

$141.4M

BioSniper AIPage evidence connected

Prepared research question

What matters most for Terns Pharmaceuticals, Inc. (TERN)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
TERNTerns Pharmaceuticals, Inc.312,181$16.5M
RYTMRHYTHM PHARMACEUTICALS, INC.165,599$14.4M
JAZZJazz Pharmaceuticals plc73,222$13.8M
COGTCogent Biosciences, Inc.293,780$11.3M
DNTHDianthus Therapeutics, Inc. /DE/100,044$8.4M
CNTACentessa Pharmaceuticals plc206,847$8.2M
ZYMEZymeworks Inc.321,427$8.0M
CLDXCelldex Therapeutics, Inc.236,637$7.5M
BMRNBIOMARIN PHARMACEUTICAL INC90,632$5.1M
ADPTAdaptive Biotechnologies Corp317,624$4.4M
PCVXVaxcyte, Inc.74,842$4.3M
INSMINSMED Inc23,153$3.8M
CYTKCYTOKINETICS INC49,711$3.3M
NKTRNEKTAR THERAPEUTICS42,624$3.1M
ELVNEnliven Therapeutics, Inc.68,706$2.7M
AXSMAxsome Therapeutics, Inc.15,304$2.6M
MAZEMaze Therapeutics, Inc.83,750$2.5M
BBIOBridgeBio Pharma, Inc.31,253$2.3M
GMABGenmab A/S84,354$2.3M
SLNOSOLENO THERAPEUTICS INC56,585$1.9M
LRMRLarimar Therapeutics, Inc.379,765$1.7M
CAMPCamp4 Therapeutics Corp339,521$1.5M
IMTXImmatics N.V.151,112$1.5M
REGNREGENERON PHARMACEUTICALS, INC.1,713$1.3M
ALNYALNYLAM PHARMACEUTICALS, INC.3,611$1.2M
ALGSAligos Therapeutics, Inc.148,799$1.1M
IRONDisc Medicine, Inc.13,820$884K
PHVSPharvaris N.V.29,184$824K
APLSApellis Pharmaceuticals, Inc.20,351$819K
RCUSArcus Biosciences, Inc.34,219$739K
QNRXQuoin Pharmaceuticals, Ltd.100,300$662K
ORICOric Pharmaceuticals, Inc.42,446$538K
SUPNSUPERNUS PHARMACEUTICALS, INC.9,045$468K
IBRXImmunityBio, Inc.48,800$374K
TGTXTG THERAPEUTICS, INC.10,217$339K
TNGXTango Therapeutics, Inc.12,535$262K
SNYSanofi5,157$248K
OGNOrganon & Co.23,455$140K
LCTXLineage Cell Therapeutics, Inc.60,833$96K
OCGNOcugen, Inc.41,816$76K
XFORX4 Pharmaceuticals, Inc11,200$46K
IVVDInvivyd, Inc.28,800$37K
CCCCC4 Therapeutics, Inc.10,466$28K
PROKPROKIDNEY CORP.14,600$26K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.